Gemcitabine (GEM) and liposomal doxorubicin (PLD) in recurrent/metastatic breast carcinoma: A phase II study

Authors :: F. Ferraù
G. Condemi
Giovanni Scambia
C. Garipoli
V. Adamo
M. Spada
Domenica Lorusso
Rosalba Rossello
L Di Lullo
Gabriella Ferrandina
Source :: Journal of Clinical Oncology. 23:790-790
Publication Year :: 2005
Publisher :: American Society of Clinical Oncology (ASCO), 2005.
Abstract: 790 Background: Aim of the study was to assess the efficacy and safety of the combination gemcitabine (GEM) and liposomal doxorubicin (PLD) in patients (pts) with measurable recurrence/metastasis f...

Subjects :: Cancer Research
medicine.medical_specialty
endocrine system diseases
business.industry
Liposomal Doxorubicin
Phases of clinical research
Metastatic Breast Carcinoma
medicine.disease
Gemcitabine
Metastasis
Surgery
Oncology
Cancer research
medicine
lipids (amino acids, peptides, and proteins)
In patient
business
medicine.drug

Tools